Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1
- 14 January 2016
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (7) , 9189-9196
Abstract
Esophageal squamous cell carcinoma (ESCC) is the most common cancer in China, and multidrug resistance (MDR) remains one of the biggest problems in ESCC chemotherapy. In this study, we aimed to investigate the mechanism of Caveolin-1, an integral membrane protein, on regulating ESCC MDR. First, immunohistochemistry was used to check the protein expression of Caveolin-1, MDR-related protein of P-glycoprotein (P-gp), and multidrug resistance protein 1 (MRP1) in 84 pathologically characterized ESCC tissues, matched adjacent tumor, and adjacent normal-looking tissues. The results showed that Caveolin-1 expression level was elevated in ESCC tissues than that of matched adjacent tumor and adjacent normal-looking tissues (P < 0.05), and the expression of Caveolin-1 has close correlation with P-gp and MRP1 during tumor genesis of ESCC (P = 0.034, P = 0.009, respectively). Then, Caveolin-1 overexpression and knockdown were used to investigate its effect on expressions of P-gp and MRP1 in ESCC cell line Ec9706. The messenger RNA (mRNA) and protein expression levels of P-gp and MRP1 were checked by real-time quantitative reverse transcription-PCR (qRT-PCR) and Western blot (WB). The results showed that Caveolin-1 overexpression significantly promotes the mRNA and protein expression of MRP1 (P < 0.05), while almost has no effect on the mRNA and protein expression of P-gp (P > 0.05); Cavoelin-1 knockdown inhibits the mRNA and protein expressions of both P-gp and MRP1 (P < 0.05). The similar result was found in another ESCC cell line Eca109. So, it is concluded that Caveolin-1 affects ESCC MDR by regulating the expressions of P-gp and MRP1; therefore, it can be taken as a significant marker and target in tumor therapy.Keywords
Funding Information
- National Natural Science Foundation of China (CN) (81101686)
- Foundation of He’nan Educational Committee (12A310008, 15A310029)
This publication has 30 references indexed in Scilit:
- Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events InvolvedPLOS ONE, 2013
- Caveolin‐1 as a promoter of tumour spreading: when, how, where and whyJournal of Cellular and Molecular Medicine, 2013
- Constitutive AhR activation leads to concomitant ABCG2‐mediated multidrug resistance in cisplatin‐resistant esophageal carcinoma cellsMolecular Carcinogenesis, 2011
- Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-Ag and caveolin-1 in lipid raftsThe International Journal of Biochemistry & Cell Biology, 2010
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell CarcinomaDigestive Diseases and Sciences, 2009
- Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated CytotoxicityJournal of Biological Chemistry, 2007
- Modulation of p‐glycoprotein function by caveolin‐1 phosphorylationJournal of Neurochemistry, 2007
- Suppression of P‐glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin‐1FEBS Letters, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Molecular and Cellular Biology of CaveolaeTrends in Cardiovascular Medicine, 1997